Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-030093)

Filing Details

Accession Number:: 0001209191-18-030093
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-05-15 06:04:15
Reporting Period:: 2018-05-14

Accepted Time:: 2018-05-15 06:04:15
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
944809	Opko Health Inc.	OPK	Pharmaceutical Preparations (2834)	752402409

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1735476	Scott Robert Fishel	4400 Biscayne Blvd. Miami FL 33137		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-05-14	1,800	$4.79	4,055,728	No	4	P	Indirect	ALSAR Ltd. Partnership

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	ALSAR Ltd. Partnership

Footnotes

These securities are held by ALSAR Ltd. Partnership, of which Dr. Fishel is the President and CEO. The general partner of ALSAR Ltd. Partnership is SARAL Corporation. Dr. Fishel is the sole shareholder and the sole and exclusive beneficiary of SARAL Corporation.